NASDAQ:TENK TenX Keane Acquisition (TENK) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.65▼$1.8650-Day Range$1.62▼$40.5052-Week Range$9.54▼$49.00Volume68,758 shsAverage Volume65,453 shsMarket Capitalization$11.78 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisCompetitorsHeadlinesOwnershipShort InterestTrendsStock AnalysisCompetitorsHeadlinesOwnershipShort InterestTrends Get TenX Keane Acquisition alerts: Email Address Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share About TenX Keane AcquisitionTenX Keane Acquisition does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses operating in Asia, excluding companies located or operating in mainland China, Hong Kong, or Macau. TenX Keane Acquisition was incorporated in 2021 and is based in New York, New York.Read More Ad Mode MobilePre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open.Claim Exclusive 100% Bonus: $0.25/Share TENK Stock News HeadlinesAugust 14, 2024 | finanznachrichten.deCitius Pharmaceuticals, Inc.: Citius Pharmaceuticals Completes Merger of Subsidiary with TenX Keane to form Citius Oncology, Inc.August 6, 2024 | finanznachrichten.deCitius Pharmaceuticals, Inc.: Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology, Inc.September 7, 2024 | Golden Crest (Ad)Biden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.August 5, 2024 | marketwatch.comTenX Keane Acquisition Shares Rise After Merger ApprovalFebruary 14, 2024 | finance.yahoo.comCitius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business UpdateJanuary 10, 2024 | finance.yahoo.comTenX Keane Acquisition Announces Contribution to Trust Account in Connection with Extension Amendment ProposalOctober 31, 2023 | investing.comTenX Keane Acquisition (TENK)October 26, 2023 | msn.comCitius unit to merge with TenX Keane to form public companySeptember 7, 2024 | Porter & Company (Ad)Why billionaires are wiring money to abandoned towns A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution. August 23, 2023 | health.usnews.comMatthew G. KeaneJuly 18, 2023 | seekingalpha.comTenX Keane Acquisition to extend date for completion of business combinationJuly 18, 2023 | finance.yahoo.comTenX Keane Acquisition Announces Extension of the Deadline for an Initial Business CombinationJune 26, 2023 | mirror.co.ukRoy Keane outlines his "worry" for Man Utd ahead of FA Cup final vs Man CityMay 13, 2023 | investing.comPAY/BTC - TenX BitcoinJanuary 6, 2023 | morningstar.comEpiphany Technology Acquisition Corp Ordinary Shares - Class ADecember 14, 2022 | money.usnews.comFigure Acquisition Corp I - Ordinary Shares - Class ASee More Headlines Receive TENK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TenX Keane Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today9/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TENK CUSIPN/A CIK1851484 Webwww.tenxkeane.com Phone347-627-0058FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,653,000Free Float5,129,000Market Cap$11.78 million OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Xiaofeng Yuan (Age 52)CEO & Chairman Mr. Dahe Zhang (Age 46)CFO & Executive Director Key CompetitorsAnebulo PharmaceuticalsNASDAQ:ANEBAtara BiotherapeuticsNASDAQ:ATRARallybioNASDAQ:RLYBvTv TherapeuticsNASDAQ:VTVTAadi BioscienceNASDAQ:AADIView All CompetitorsInstitutional OwnershipLogan Stone Capital LLCBought 243,158 shares on 8/15/2024Ownership: 3.657%Glazer Capital LLCSold 4,569 shares on 8/14/2024Ownership: 4.612%Cowen AND Company LLCBought 112,667 shares on 8/7/2024Ownership: 9.431%Wolverine Asset Management LLCSold 5,219 shares on 8/2/2024Ownership: 6.125%View All Institutional Transactions TENK Stock Analysis - Frequently Asked Questions Who are TenX Keane Acquisition's major shareholders? Top institutional shareholders of TenX Keane Acquisition include Cowen AND Company LLC (9.43%), Wolverine Asset Management LLC (6.13%), Glazer Capital LLC (4.61%) and Logan Stone Capital LLC (3.66%). This page (NASDAQ:TENK) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TenX Keane Acquisition Please log in to your account or sign up in order to add this asset to your watchlist. Share TenX Keane Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.